Seeking Alpha

Baxter International (BAX) trades 3.8% lower premarket after it discloses along with partner...

Baxter International (BAX) trades 3.8% lower premarket after it discloses along with partner Halozyme Therapeutics that the FDA needs more long-term data on their jointly-developed HyQ product.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)